Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026)

Axsome Therapeutics (AXSM) reported Current Taxes of $99000.0 for Q1 2026, down 89.69% on a YoY basis from $960000.0 in Q1 2025, and down 1.98% sequentially from $101000.0 in Q4 2025.

Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026) Analysis & Trends

Axsome Therapeutics (AXSM) has 3 years of Current Taxes data on file, last reported at $99000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Taxes fell 89.69% year-over-year to $99000.0; the trailing twelve-month figure through Mar 2026 stood at $99000.0 (down 89.69% YoY), and the FY2025 full-year result was $101000.0, down 89.48% from the prior year.
  • Current Taxes declined to $99000.0 in Q1 2026, from $101000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $960000.0 in Q4 2024 to a low of $99000.0 in Q1 2026.
  • A 3-year average of $514000.0 and a median of $493000.0 in 2024 frame the typical range for Current Taxes.
  • Across the five-year window, Current Taxes surged 95.12% in 2025 and slumped 89.69% in 2026, its largest moves.
  • Tracing AXSM's Current Taxes over 3 years: stood at $960000.0 in 2024, then sank by 89.48% to $101000.0 in 2025, then fell by 1.98% to $99000.0 in 2026.
  • Business Quant data shows AXSM's Current Taxes at $99000.0 in Q1 2026, $101000.0 in Q4 2025, and $960000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn 63.52 Mn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn -
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn 49.00 Mn
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn -
10 Axsome Therapeutics 12.27 Bn 11.97 Bn 176.48 Mn 99,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 99,000.00
Dec 31, 2025 101,000.00
Mar 31, 2025 960,000.00
Dec 31, 2024 960,000.00
Sep 30, 2024 493,000.00
Jun 30, 2024 493,000.00
Mar 31, 2024 492,000.00